My husband has a chance for a cure.  He is patient #3 in a first in human clinical trial for kidney cancer and I’ll be sharing part of his journey here.

His name is Ralph Knapp, he’s 57 and was diagnosed 4.5 years ago with stage IV Kidney Cancer.  This will be his 8th different treatment and 4th clinical trial.  He has been treated in 3 different NCI – Designated Cancer Centers around the country.  To say he is a fighter is an understatement.

Very few patients with advanced kidney cancer have long term durable responses. None of the drug options currently available to Ralph offer a hope for a cure and little hope for stability.  The past 4.5 years we have chased one treatment after another and seen Ralph’s cancer recur and progress.  We are now chasing a cure.

Somehow I knew we would eventually end up at the largest hospital devoted solely to clinical investigation in the world – The National Institutes of Health or NIH.

The HERV-E trial is a gene transfer therapy trial, in which a patient’s own T-Cells are modified genetically and reintroduced into the body.  This is the first time they have investigated this therapy in kidney cancer.  Also literally a first in human clinical trial since mice don’t have the genetic makeup for this study.  Ralph was approved for the trial based on DNA testing that was done through saliva.  For more scientific analysis of the trial – click HERE.

This is a phenomenal opportunity for Ralph.   He is one of the lucky 15-18% of Caucasians that have this genetic marker and a chance for a cure.  Stay tuned.

 

WHO WE ARE →

WHAT WE DO →

OUR STORIES →

THE KIDNEY CANCER COMMUNITY →

SCIENTIFIC ADVISORS →

DONATE →

CONTACT →

Latest News

Debra Beyhan: Embracing the Ups and Downs of Life with Kidney Cancer

Debra Beyhan: Embracing the Ups and Downs of Life with Kidney Cancer

Deb Beyhan is the Patient Legislative Advocate for KidneyCAN. She was diagnosed with stage IV kidney cancer in 2016 at the age of 53. Deb lives outside of Atlanta, GA, with her husband.    For this month's Community Spotlight, we want to tell you about a member of our volunteer team, Deb Beyhan....

DISTRICT DAYS 2022 →

SPRING ADVOCACY DAYS 2022 →

JOIN OUR COMMUNITY →

RAISING AWARENESS →

BE AN ADVOCATE →

DONATE NOW →

CONTACT →

Latest News

District Days: Asking Congress to Fund Kidney Cancer Research

District Days: Asking Congress to Fund Kidney Cancer Research

On August 8-9th, KidneyCAN gathered advocates from all over the United States to ask Congress for robust funding for kidney cancer research through the NIH and CDMRP (Congressionally Directed Medical Research Programs). Read on to hear about our goals for this event and how you can help fund...

Patient Resource Center

UNDERSTANDING YOUR KIDNEY CANCER DIAGNOSIS

BUILDING YOUR CARE TEAM

TREATMENT & TRIAL OPTIONS

LIVING WELL WITH KIDNEY CANCER

CLINICAL TRIALS →

IMMUNOTHERAPY →

KCRS: KIDNEY CANCER RESEARCH SUMMIT →

RESEARCH OPPORTUNITIES →

NEWS →

Latest News

The 2022 Kidney Cancer Research Summit

The 2022 Kidney Cancer Research Summit

Dr. Laurence Albiges (Institut Gustave Roussy) presents on the microbiome at KCRS22. The microbiome has now been recognized as one of the emerging hallmarks and enabling characteristics of cancer. KidneyCAN hosted the 4th Annual Kidney Cancer Research Summit on October 6-7, 2022  live in...

SUPPORT OUR WORK →

FUNDRAISE FOR KIDNEYCAN →

DONATE →

CONTACT →

Latest News

Rock the Run for Kidney Cancer Research Funding

Rock the Run for Kidney Cancer Research Funding

KidneyCAN had the first ever Rock the Run 5k fundraiser in October 2022. This is part of the group of KCRS22 attendees who walked and ran with us at dawn before the second conference day began. KidneyCAN is proud to share the results of the first annual Rock the Run 5K fundraiser. Our Purpose...